| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 48.105 | 28.305 | 21.436 | 12.851 | 18.236 |
| Total Income - EUR | - | - | - | - | - | 48.105 | 28.305 | 21.436 | 12.851 | 18.236 |
| Total Expenses - EUR | - | - | - | - | - | 27.250 | 12.424 | 19.362 | 32.290 | 31.415 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 20.854 | 15.881 | 2.074 | -19.439 | -13.180 |
| Net Profit/Loss - EUR | - | - | - | - | - | 20.420 | 15.632 | 1.886 | -19.567 | -13.180 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Proexib Design S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 8 | 2.132 | 5.763 | 4.604 | 3.945 |
| Current Assets | - | - | - | - | - | 24.482 | 20.046 | 17.804 | 10.659 | 12.121 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 695 | 6.148 | 2.488 | 4.651 | 8.550 |
| Cash | - | - | - | - | - | 23.788 | 13.897 | 15.316 | 6.008 | 3.571 |
| Shareholders Funds | - | - | - | - | - | 20.462 | 16.489 | 3.482 | -16.096 | -29.186 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 4.029 | 5.689 | 20.085 | 31.360 | 45.281 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Proexib Design S.r.l.